APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 323 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $337,161 | +14.3% | 3,701 | -14.2% | 0.00% | -50.0% |
| Q3 2022 | $295,000 | -49.5% | 4,314 | -68.3% | 0.00% | -33.3% |
| Q1 2021 | $584,000 | +15.9% | 13,611 | +54.6% | 0.00% | +50.0% |
| Q4 2020 | $504,000 | +97.6% | 8,805 | +4.3% | 0.00% | +100.0% |
| Q3 2020 | $255,000 | – | 8,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |